Czech Deputy Well being Minister Michaela Matoušková (STAN, EPP) is asking for stronger EU motion on pharmaceutical coverage, higher coordination on digital well being, and a extra unified strategy to affected person entry to revolutionary medicines throughout the bloc.
In an interview with Euractiv, Matoušková urged the EU to maneuver from passive coordination to proactive assist, notably in the case of making certain equitable entry to revolutionary medicines and constructing the Union’s strategic autonomy in healthcare.
Matoušková, who took workplace in February this yr, believes the COVID-19 pandemic and the EU’s fragmented response uncovered structural weaknesses that Brussels now has a possibility to handle. “We’ve the brains, however we lack coordination – and that’s the function of the European Union,” she mentioned.
She argues that the EU degree is the one viable area to sort out the uneven and delayed entry to new medicines that persists throughout member states.
“Some smaller states don’t introduce medicines, despite the fact that the European Medicines Company (EMA) has accepted them, as rapidly as others. If we actually need a patient-focused strategy, this has to vary,” she mentioned.
The Czech deputy minister voiced robust assist for the pharmaceutical package deal at the moment negotiated by EU establishments within the trilogues. Nevertheless, she underlined that success will rely upon discovering the best steadiness between affected person entry, worth and business incentives. “The compromise is essential,” she mentioned.
She famous that the Fee’s proposal rightly goals to extend entry to medicines in all member states, however that it will require cooperation from business. “They should perceive what we try to realize: pace of rollout and availability,” Matoušková mentioned.
Innovation vouchers
Considered one of her issues is the rising development of pharmaceutical firms threatening to tug out of Europe in response to proposed modifications in market exclusivity guidelines. “The USA invests considerably extra – 3 times greater than the EU, I imagine. But it surely’s not nearly cash. It’s about how briskly we carry medicines to market and the way lengthy the information and market safety lasts,” she mentioned.
Matoušková acknowledged the monetary pressures innovators face and expressed assist for sustaining incentives that enable for returns on funding.
To bridge the pursuits of each sufferers and business, she supported “a system of innovation vouchers” as a complementary instrument to assist quicker growth and approval of recent medicine, whereas sustaining funding enchantment.
She additionally addressed the broader relationship between innovation and generics, noting, “I believe generics will at all times be right here. However we have to push for innovation, that’s what we have to defend.”
Matoušková additionally sees digital well being as an space the place EU management is urgently wanted.
Whereas the European Well being Knowledge House regulation has opened a promising debate, the deputy minister warns that implementation is lagging in some areas. “We wish to have shared medical documentation, however we’re lacking regional knowledge networks. We do not need sufficient infrastructure to make it work,” mentioned Matoušková.
She believes the EU ought to step in with funding and coordination. “The EU ought to present the authorized framework, the circumstances, and the funding. The EU needs to be the roof over the entire construction,” she mentioned.
Cross-border cooperation
Her ambition can be to see larger EU involvement in cross-border emergency providers. “Why do we want bilateral treaties for cross-border emergency care? We might outline it on the EU degree,” she mentioned.
In the long term, Matoušková urges Brussels to spend money on providers that replicate demographic modifications and make a distinction on the bottom, akin to palliative care and home-based assist for older folks. “Personally, I’m not a fan of constructing extra amenities. Care ought to transfer nearer to sufferers, into the sphere, into their houses,” she mentioned.
She would additionally welcome extra EU steering on workforce reform, together with a broader debate on prescription rights for certified non-physician personnel, including that, “We’ve very erudite non-physician professionals in Czechia, however they haven’t been granted the suitable competences.”
Her message to EU policymakers is obvious: well being coverage have to be handled as a strategic funding. “We should always see the EU not as a repressive physique, however as a supply of change – an establishment that helps innovation. Not as a dictator, however as a associate that helps deal with our wants,” she mentioned.
[Edited by Vasiliki Angouridi, Brian Maguire]
Keep forward of the curve with NextBusiness 24. Discover extra tales, subscribe to our publication, and be part of our rising group at nextbusiness24.com
